Skip to content
AMR continues to pose a global threat
September was a big month for those following antimicrobial resistance (AMR). A new study highlighted the growing public health burden of AMR, and the […]
AMR continues to pose a global threat Read More »
BIO speaks on Capitol Hill about mpox preparedness
Mpox has proven to be a major public threat since its resurgence globally during the COVID years. As Bio.News reported, “On Aug. 14, the
BIO speaks on Capitol Hill about mpox preparedness Read More »
Sepsis Awareness Month: 3 things you need to know about sepsis
September is Sepsis Awareness Month, and the Biotechnology Innovation Organization (BIO) is partnering with Sepsis Alliance to spread the word about sepsis and provide
Sepsis Awareness Month: 3 things you need to know about sepsis Read More »
BIO and BBC StoryWorks call for biotech stories
Since 2019, the Biotechnology Innovation Organization (BIO) has worked with BBC StoryWorks Commercial Productions, the BBC’s award-winning branded content division, to bring stories of
BIO and BBC StoryWorks call for biotech stories Read More »
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward
“The world of biotechnology is in the midst of a wave of exciting research and clinical advances—from artificial intelligence-based drug discovery to cell and
GEN State of Biotechnology 2024: John F. Crowley on driving biotech forward Read More »
BIO at the World AMR Congress: ‘We know we’re racing against time’
Antimicrobial resistance (AMR) is one of the clear and present threats of our time, and if left unchecked could have dire consequences. In 2019,
BIO at the World AMR Congress: ‘We know we’re racing against time’ Read More »
First mpox vaccines arrive in DRC, epicenter of the international emergency
The first shipment of Jynneos mpox vaccines arrived in the Democratic Republic of Congo (DRC) on Sept. 5, according to vaccine maker Bavarian Nordic.
First mpox vaccines arrive in DRC, epicenter of the international emergency Read More »
BIO Start-Up Stadium 2024: Meet Seed-Stage winner Afreen Allam and SiNON Nano Sciences
Afreen Allam’s company, SiNON Nano Sciences, has been working tirelessly to overcome one of the most significant challenges in neurology: enabling drugs to cross
BIO Start-Up Stadium 2024: Meet Seed-Stage winner Afreen Allam and SiNON Nano Sciences Read More »
Merck for Mothers addresses maternal cardiovascular risks
Pregnancy-related deaths in the U.S. have risen 140% over the past three decades, and cardiovascular disease is the leading cause, according to the American
Merck for Mothers addresses maternal cardiovascular risks Read More »
FNIH’s new Parkinson’s program proves collaboration is key
Soania Mathur, a former family physician, who has had Parkinson’s disease for over 25 years, believes she knows what’s best for her. “As patients
FNIH’s new Parkinson’s program proves collaboration is key Read More »